Industry
Medical - Devices
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
August 01, 2024 | 1:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 12:46 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 10:27 am
Portfolio Pulse from Benzinga Newsdesk
July 31, 2024 | 8:55 pm
Portfolio Pulse from Benzinga Newsdesk
July 31, 2024 | 8:25 pm
Portfolio Pulse from Benzinga Newsdesk
July 31, 2024 | 8:11 pm
Portfolio Pulse from Benzinga Insights
July 24, 2024 | 8:00 pm
Portfolio Pulse from Benzinga Insights
July 15, 2024 | 7:31 pm
Portfolio Pulse from Benzinga Newsdesk
July 15, 2024 | 4:51 pm
Portfolio Pulse from Benzinga Insights
July 15, 2024 | 2:01 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.